Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42021-01-266OAAI
Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42021-01-264OAAI
Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42020-11-095OAAI
Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42020-03-056OA
Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42020-01-103OAAI
Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosisCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42019-09-2411OAAI
Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysisJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGYIF82014-11-21115PREAI